Evidence map›Paper›PMID 30795785›Full record

Trial reportSubstance abuse treatment, prevention, and policy2019

The effects of crocin on psychological parameters in patients under methadone maintenance treatment: a randomized clinical trial.

Anahita Khalatbari-Mohseni, Hamid Reza Banafshe, Naghmeh Mirhosseini, Zatollah Asemi, Amir Ghaderi, Abdollah Omidi

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Substance abuse treatment, prevention, and policy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Current pharmaceutical design · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Saffron (Nutrients · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Plants with Anti-Addictive Potential.Advances in experimental medicine and biology · 2021
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Anahita Khalatbari-MohseniDepartment of Addiction studies, School of Medical, Kashan University of Medical Sciences, Kashan, Iran.
Hamid Reza BanafsheDepartment of Addiction studies, School of Medical, Kashan University of Medical Sciences, Kashan, Iran.
Naghmeh MirhosseiniSchool of Public Health, University of Saskatchewan, Saskatoon, SK, Canada.
Zatollah AsemiResearch Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R., Iran.
Amir GhaderiDepartment of Addiction studies, School of Medical, Kashan University of Medical Sciences, Kashan, Iran.
Abdollah OmidiDepartment of clinical psychology, School of Medicine, Kashan University of Medical Science, Kashan, Iran. abomidi20@yahoo.com.
Kashan University of Medical Sciences · IRUniversity of Saskatchewan · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMethadone maintenance treatment (MMT) might be associated with the symptoms of depression and anxiety, sleep disturbances and sexual dysfunctions. This study was designed to determine the effects of crocin on psychological parameters in patients under MMT.

methodsPatients under MMT were randomly allocated into two groups to receive either 30 mg/day crocin (2 plus crocin tablet, 15 mg BID) (n = 25) or placebo (2 tablets per day, 15 mg BID) (n = 25), one hour after taking food, for 8 weeks. Psychological parameters were evaluated at baseline and end of the trial to determine related associations between crocin and patients' mental health status.

resultsAfter 8-week intervention, crocin significantly decreased Beck Depression Inventory (b - 6.66; 95% CI, - 9.88, - 3.45; P < 0.0001), Beck Anxiety Inventory (b - 4.35; 95% CI, - 5.94, - 2.75; P < 0.0001), general health questionnaire (b - 4.45; 95% CI, - 7.68, - 1.22; P = 0.008) and Pittsburgh Sleep Quality Index (b - 2.73; 95% CI, - 3.74, - 1.73; P < 0.0001) in patients under MMT, compared with the placebo. Crocin also significantly improved International Index of Erectile Functions (b 4.98; 95% CI, 2.08, 7.88; P = 0.001) rather than placebo.

conclusionOur findings indicated that taking crocin for 8 weeks by patients under MMT had beneficial effects on their mental health status. Crocin can be recommended as an adjunct to methadone in opioid withdrawal protocols because of the ability to improve the quality of life and decrease opioids side effects in these patients. This trial was registered in the Iranian website for clinical trials registry as http://www.irct.ir : IRCT2017110537243N1. CLINICAL TRIAL REGISTRATION NUMBER: www.irct.ir: http://www.irct.ir: IRCT2017110537243N1 .

Indexed as

AdultAnxietyCarotenoidsDepressionDouble-Blind MethodDrug Therapy, CombinationHumansMethadoneOpiate Substitution TreatmentPsychiatric Status Rating ScalesSexual Dysfunctions, PsychologicalSleep Wake DisordersCarotenoidscrocinMethadoneCrocinMethadone maintenance treatmentPsychological parameters

Identifiers

PMID30795785
PMCPMC6387551
OpenAlexW2929767411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.